DAY 4 - Tuesday, April 29
SURGERY
Collagen CXL in young keratoconic patients
Collagen crosslinking (CXL) provides good results in young patients with keratoconus, but the key to success in these young patients is rapid treatment upon presentation without waiting for disease progression, said Paolo Vinciguerra, MD.
» MORE
|
|
Potential uses for collagen crosslinking
Collagen crosslinking (CXL) is currently used to treat keratoconus, pellucid marginal degeneration, and post-LASIK ectasia, although it has not yet received FDA approval. Thomas John, MD, discussed the potential of the technology to treat corneal infections. » MORE
|
|
Combining CXL with corneal implants
Combination therapy of collage crosslinking (CXL) and corneal implants (Intacs, Addition Technology) may be a good treatment for mild-to-moderate keratoconus, according to David Rootman, MD. » MORE
|
|
Lenticule extraction procedure predictable
Femtosecond laser lenticule extraction (small-incision lenticule extraction) performed to treat spherical myopia resulted in rapid and significant improvements in visual acuity. John Doane, MD, reported the preliminary data from the U.S. clinical trial. » MORE
|
|
DGH introduces new pachymeters
Two new pachymeters—Pachmate 2 and Pachette 4—were introduced by DGH Technology. Both devices feature an exclusive memory system that stores multiple patient records for automatic report generation using wireless technology.
» MORE
|
DISCLAIMER:
This information has been independently developed and provided by the editors of Ophthalmology Times. The sponsor does not endorse and is not responsible for the accuracy of the content or for practices or standards of non-sponsor sources.
| |
|
 Top Tweets
|
|
We welcome your feedback!
Please send your comments to:
Mark L. Dlugoss
Group Content Director
Advanstar Eye Health Group
mdlugoss@advanstar.com |
|
|
